---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-22-023298"
form_type: "8-K"
ticker: "AURX"
cik: "0001091596"
company_name: "Nuo Therapeutics, Inc."
filed_at: "2022-09-30T23:59:59+00:00"
generated_at: "2026-06-23T06:16:06.251297+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Nuo Therapeutics sets 2022 Annual Meeting for Dec 2; record date Sept 30

## Summary
- Annual Meeting will be held at 8285 El Rio, Suite 190, Houston, Texas on December 2, 2022.
- Stockholders of record as of September 30, 2022 are entitled to vote.
- Deadline for shareholder proposals and director nominations is October 10, 2022.
- Proposals must be submitted in writing to Secretary David Jorden at the company's address.

## SEC filing metadata
- accession: 0001437749-22-023298
- form_type: 8-K
- ticker: AURX
- cik: 0001091596
- company_name: Nuo Therapeutics, Inc.
- filed_at: 2022-09-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.08, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1091596/000143774922023298/0001437749-22-023298-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1091596/000143774922023298/aurx20220926_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-22-023298
- JSON: https://secwatch.observer/filing/0001437749-22-023298.json
- Plain text: https://secwatch.observer/filing/0001437749-22-023298.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.